# Glycans Bound to Serum Haptoglobin: a Novel Gastric Cancer Tumor Biomarker

> **NCT02848066** · — · COMPLETED · sponsor: **Samsung Medical Center** · enrollment: 353 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **PROCEDURE:** Blood sample(10cc) collection

## Key facts

- **NCT ID:** NCT02848066
- **Lead sponsor:** Samsung Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2016-08
- **Final completion:** 2017-09
- **Target enrollment:** 353 (ACTUAL)
- **Last updated:** 2019-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02848066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02848066, "Glycans Bound to Serum Haptoglobin: a Novel Gastric Cancer Tumor Biomarker". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02848066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*